Net Sales are expected to increase by 16.1 percent Y-o-Y (up 8.4 percent Q-o-Q) to Rs. 2,787.1 crore, according to Kotak.
"We are bringing down the debt from Rs 3300 crore to Rs 2500 crore by the end of the financial year," said Suneeta Reddy, Managing Director of Apollo Hospitals to Moneycontrol.
The hospital chain will wait for surgery and treatment rates to be raised before participating in the programme in metro cities.
A list of stocks which are in focus because of their price action. The technical outlook is limited to near and medium-term.
The promoter family holding in the AHEL now has come down to 30.8 percent, it added.
The overall demand for Gold and silver investments have also increased in the current period to an all-time high, due to volatile Indian equity markets and further concerns about the health of the Indian economy.
On September 3, thirty stocks had hit fresh 52-week highs. Meanwhile, the market was witnessing one of its biggest falls in recent months, with Sensex down 800 points and Nifty wiped off nearly 200 points.
We have collated a list of stocks which remained in focus on Wednesday because of their price action. The technical outlook is for the near to medium term.
Under the MoU, EESL will make the entire upfront investment on specified services and deploy qualified manpower for the operation and maintenance of the public charging infrastructure.
The short covering can take the Nifty50 back towards 11,350. However, 10780 should hold good in August provided there is no negative surprise from international markets.
ICICI Direct recommended hold rating on Apollo Hospitals with a target price of Rs 1500 in its research report dated August 16, 2019.
Consolidated revenue from operations stood at Rs 2,571.89 crore during the quarter under review as against Rs 2,210.47 crore in the same period a year ago
According to the release, Cardiovascular diseases (CVDs) are the biggest cause of mortality in India with nearly 25% mortalities in the age group of 25 to 69 years.
Net Sales are expected to increase by 17.7 percent Y-o-Y (up 2.9 percent Q-o-Q) to Rs. 2,594.8 crore, according to Kotak.
Trends on SGX Nifty indicate a positive opening for the broader index in India, a rise of 39 points or 0.34 percent. Nifty futures were trading around 11,533-level on the Singaporean Exchange.
Trends on SGX Nifty indicate a positive opening for the broader index in India, a rise of 9.5 points or 0.08 percent. Nifty futures were trading around 11,847-level on the Singaporean Exchange.
A bench headed by Chief Justice Ranjan Gogoi was hearing the appeal of Apollo Hospitals against the April 4 order of the Madras High Court rejecting its objection against the ongoing inquiry into the death of the AIADMK leader at the hospital.
Net Sales are expected to increase by 17.3 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 2,475.3 crore, according to Kotak.
The submissions on behalf of the hospital were made by senior counsel Aryama Sundaram before a division bench of justices R Subbiah and Krishnan Ramasamy.
ICICI Direct is bullish on Apollo Hospitals has recommended buy rating on the stock with a target price of Rs 1400 in its research report dated February 11, 2019.
The hospital wanted the court to quash government orders that brought medical treatment to the late leader under the Terms of Reference of the Justice A Arumughaswamy Commission of Inquiry (CoI).
Earnings growth for FY20 will get better by H2FY20 led by positive lag-effect of reforms,” says Vinod Nair, Head Of Research at Geojit Financial Services
Net Sales are expected to increase by 13.2 percent Y-o-Y (up 2.7 percent Q-o-Q) to Rs. 2,145.8 crore, according to ICICI Direct.
Harendra Kumar of Elara Capital said given the overall robustness in earnings recovery, 2019 could well be a year of midcaps and smallcaps.
Net Sales are expected to increase by 13 percent Y-o-Y (up 9.5 percent Q-o-Q) to Rs. 2,092.4 crore, according to ICICI Direct.